
Pregavin M 750mcg/75mg Tablet SR
Marketer
Isis Healthcare Pvt Ltd
Salt Composition
Methylcobalamin (750mcg) + Pregabalin (75mg)
Overview Pregavin M 750mcg/75mg Tablet SR
Neuropathic pain is treated with the prescription medication Pregavin M 750mcg/75mg Tablet SR. Its mechanism involves regulating nerve cell calcium channel activity to reduce pain, while also safeguarding and repairing nerve fibers. Administered orally, with or without food, ideally before sleep, consistent daily timing ensures stable blood levels. Follow your physician's prescribed dosage and duration; this medication can be habit-forming. Missed doses should be taken immediately upon recall. Complete the entire course, even with symptom improvement. Abrupt cessation requires prior consultation with your doctor. Common, generally mild, side effects—improving over time—include nasal congestion, increased appetite, elevated mood, tremors, blurred vision, dry mouth, dizziness, and drowsiness. Avoid activities demanding concentration until the drug's effects are understood. Weight gain is possible; mitigate this through exercise and a balanced diet. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Always disclose all other medications you are using, as interactions may reduce Pregavin M's efficacy or alter its action. Notify your doctor of pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Pregavin M 750mcg/75mg Tablet SR
No text was provided. Please provide the text you wish me to rewrite.
Uses of Pregavin M 750mcg/75mg Tablet SR
Managing neuropathic pain
Major Benefits of Pregavin M 750mcg/75mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pregavin M 750mcg/75mg Tablet SR whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent daily timing is recommended.
Common Side effects of Pregavin M 750mcg/75mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Pregavin M 750mcg/75mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length of this medication. Ingest the Pregavin M 750mcg/75mg Tablet SR whole; avoid crushing, chewing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Pregavin M 750mcg/75mg Tablet SR works:
Each Pregavin M 750mcg/75mg sustained-release tablet combines methylcobalamin, a vitamin B derivative, with pregabalin. Methylcobalamin aids myelin production, protecting nerve fibers and promoting nerve cell repair. Pregabalin, an alpha-2-delta ligand, reduces pain by regulating nerve cell calcium channel function. This dual action provides relief from neuropathic pain resulting from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Pregavin M 750mcg/75mg sustained-release tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Pregavin M 750mcg/75mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Pregavin M 750mcg/75mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Pregavin M 750mcg/75mg Extended-Release Tablets might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving is inadvisable if these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should use Pregavin M 750mcg/75mg Tablet SR cautiously. Dosage modification of Pregavin M 750mcg/75mg Tablet SR might be necessary. A physician's advice is recommended.
LiverSAFE IF PRESCRIBED
Use of Pregavin M 750mcg/75mg Tablet SR in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Pregavin M 750mcg/75mg Tablet SR :
Should you forget a Pregavin M 750mcg/75mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pregavin M 750mcg/75mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience and Central Nervous System |
